Clinical Study to Evaluate the Effectiveness of a Polyherbal Formulation in People with Eczema

INTERVENTION: CONDITION: Health Condition 1: L209‐ Atopic dermatitis, unspecified PRIMARY OUTCOME: Evaluate the effect of the test product on the Eczema during treatment. ; Evaluate the effect of the test products on the Eczema after treatment ; Compare the efficacy between the Trial drug 1, Trial drug 2 and the Standard DrugTimepoint: Baseline, Day 7, 14, 21, 28, 56, 84 SECONDARY OUTCOME: Evaluate the efficacy of products on Quality of LifeTimepoint: Baseline, Day 7, 14, 21, 28, 56, 84 Evaluate the efficacy on AEC valuesTimepoint: Baseline, Day 28, 84 Evaluate the efficacy on Burning SensationTimepoint: Baseline Day 7, 14, 21, 28, 56, 84 Evaluate the efficacy on ESR valuesTimepoint: Baseline, Day 28, 84 Evaluate the Efficacy on ItchingTimepoint: Baseline, Day 7, 14, 21, 28, 56, 84 Evaluate the efficacy on reduction of sleep disturbancesTimepoint: Baseline, Day 7, 14, 21, 28, 56, 84 INCLUSION CRITERIA: Male or female subjects who are diagnosed with eczema within 1 year. Subjects who have recurrent occurrence of eczema. Subjects in the age group of 18 and above. Subjects willing to give a written informed consent and agree to come for a regular follow‐up visit. Subjects who have not been diagnosed with any disease and have not consumed medicine for 15 days. Subjects willing to abide by and comply with the study protocol. Subjects who have not participated in a similar investigation in the past three months. Subjects who did not have any previous history of adverse skin conditions and were not under any medication.